Symbol
| CD55
| contributors: mct - updated : 20-10-2012
|
HGNC name
| CD55 molecule, decay accelerating factor for complement (Cromer blood group)
|
HGNC id
| 2665
|
corresponding disease(s)
|
CBGI
|
Other morbid association(s)
|
Type | Gene Modification | Chromosome rearrangement | Protein expression | Protein Function
|
---|
constitutional
|  
|  
| --low
|  
|
in red blood cells from patients with paroxismal nocturne hemoglobinuria | tumoral
|  
|  
| --over
|  
|
in colorectal cancer, and in rectal tumor tissues ( | tumoral
|  
|  
| --over
|  
|
in primary gallbladder carcinoma | constitutional
|  
|  
| --over
|  
|
in red blood cells from patients with aplastic anemia | constitutional
|  
|  
| --low
|  
|
on peripheral blood leucocytes in T2DM patients with macrovascular diseases | |
Variant & Polymorphism
|
| |
Candidate gene
Marker
| elevated leukocyte CD55 may be a useful predictor of subsequent preterm labor/birth | |
| Therapy target
|
System | Type | Disorder | Pubmed |
neurology | acquired | | |
augmenting its expression levels could be effective therapeutically in treating multiple sclerosis as well as other T cell mediated diseases |
| | |
| Cd55-deficient mice display a phenotype with about two-fold more circulating granulocytes in the blood stream, the marginated pool, and the spleen |